N@N

Louise Chen Reiterated (ACRS) at Buy and Held Target at $38 on, Sep 19th, 2023

^{Published on 2024-10-28 06:28:34 - WOPRAI, Louise Chen}
 

Louise Chen of Cantor Fitzgerald, Reiterated "Aclaris Therapeutics, Inc." (ACRS) at Buy and Held Target at $38 on, Sep 19th, 2023.

Louise has made no other calls on ACRS in the last 4 months.

There is 1 other peer that has a rating on ACRS. Out of the 1 peers that are also analyzing ACRS, 0 agree with Louise's Rating of Hold.

This is the rating of the analyst that currently disagrees with Louise

---

• Alex Thompson of "Stifel" Maintained at Strong Buy with Increased Target to $20 on, Thursday, September 14th, 2023

Contributing Sources

---